Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
What happened
The Drug Enforcement Administration (DEA) issued a temporary order to classify O-desmethyltramadol (O-DSMT), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, as a Schedule I controlled substance. This action was signed by Donald Trump and is effective from August 12, 2026, until August 12, 2028. The DEA based this decision on a finding that it is necessary to avoid an imminent hazard to public safety.
Why it matters
This order imposes strict regulatory controls, administrative, civil, and criminal penalties on O-DSMT. Substances in Schedule I have a high potential for abuse and no accepted medical use, meaning its handling will be severely restricted. It means anyone involved with O-DSMT will face legal consequences for unauthorized activities.
Who it affects
- ›Manufacturers of O-DSMT
- ›Distributors of O-DSMT
- ›Importers of O-DSMT
- ›Exporters of O-DSMT
- ›Researchers of O-DSMT
- ›People possessing O-DSMT
The receipts are official. The summary is ours.
Read on Federal Register ↗Summaries are generated from the official text and may simplify or omit nuance. The official document is the source of truth.